ruthenium has been researched along with gliclazide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Kong, Y; Liu, HK; Mao, ZW; Qian, Y; Su, Z; Wang, FX; Wang, X; Zhao, J | 1 |
1 other study(ies) available for ruthenium and gliclazide
| Article | Year |
|---|---|
Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Escherichia coli; Glycyrrhetinic Acid; HeLa Cells; Humans; Ligands; MCF-7 Cells; Molecular Structure; Organometallic Compounds; Reactive Oxygen Species; Ruthenium; Staphylococcus aureus; Structure-Activity Relationship | 2018 |